MENSINGER MIKE (Chief Product Officer) sold 8.6% of their position (7.80K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $231.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/5/2026ACC: 0002048500-26-000002
Officer· Chief Product Officer
Since Feb 2026
-7.80K
Net shares
Net seller
$231.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.20K
Price / share
$29.56
Trade value
$212.83K
% of position
7.9%
1/2/2026
90.75K→83.55K
Common Stock
Direct
Shares
−600.00
Price / share
$30.20
Trade value
$18.12K
% of position
0.7%
1/2/2026
83.55K→82.95K
Total
Net shares
−7.80K
Net value
-$230.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −7.20K | $29.56 | $212.83K | 7.9% | 90.75K | 83.55K |
| Common Stock Direct | 1/2/2026 | S · Sale | −600.00 | $30.20 | $18.12K | 0.7% | 83.55K | 82.95K |
| Total | −7.80K | -$230.95K | ||||||
Derivative Transactions0
No derivative transactions reported